Tamarack Advisers, LP
Tamarack Advisers, LP latest Q1_2021 13F filings reported $481,778,000 in market value on this 2021-05-12 report date . The portfolio quarterly return is 2.40%. This fund has 54 securities concentrations of 100% weights.
Tamarack Advisers, LP largest holding is Pacira BioSciences Inc. with weight of 8.00% and $38,550,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.
Portfolio Performance History
| FILE DATE | REPORT PERIOD | QTR YEAR | FILE TYPE | NOS. OF STOCKS | REPORTED VALUE | RETURN |
|---|---|---|---|---|---|---|
| 2021-05-12 | 2021-03-31 | Q1_2021 | 13F-HR | 54 | $481,778,000 | 2.40% |
| 2021-02-09 | 2020-12-31 | Q4_2020 | 13F-HR | 38 | $470,480,000 | 47.56% |
| 2020-11-12 | 2020-09-30 | Q3_2020 | 13F-HR | 29 | $318,836,000 | -8.43% |
| 2020-08-11 | 2020-06-30 | Q2_2020 | 13F-HR | 29 | $348,173,000 | 34.03% |
| 2020-05-14 | 2020-03-31 | Q1_2020 | 13F-HR | 30 | $259,773,000 | -40.52% |
| 2020-02-11 | 2019-12-31 | Q4_2019 | 13F-HR | 25 | $436,724,000 | 14.41% |
| 2019-11-05 | 2019-09-30 | Q3_2019 | 13F-HR | 25 | $381,728,000 | 16.17% |
| 2019-08-12 | 2019-06-30 | Q2_2019 | 13F-HR | 19 | $328,608,000 | 30.70% |
| 2019-05-13 | 2019-03-31 | Q1_2019 | 13F-HR | 20 | $251,430,000 | 2.60% |
| 2019-02-11 | 2018-12-31 | Q4_2018 | 13F-HR | 20 | $245,057,000 | -29.60% |
| 2018-11-13 | 2018-09-30 | Q3_2018 | 13F-HR | 24 | $348,092,000 | 17.24% |
| 2018-08-14 | 2018-06-30 | Q2_2018 | 13F-HR | 25 | $296,911,000 | 41.23% |
| 2018-05-08 | 2018-03-31 | Q1_2018 | 13F-HR | 27 | $210,233,000 | 15.84% |
| 2018-02-14 | 2017-12-31 | Q4_2017 | 13F-HR | 25 | $181,481,000 | 12.39% |
| 2017-11-13 | 2017-09-30 | Q3_2017 | 13F-HR | 23 | $161,479,000 | -4.94% |
| 2017-08-08 | 2017-06-30 | Q2_2017 | 13F-HR | 26 | $169,869,000 | 6.13% |
| 2017-05-12 | 2017-03-31 | Q1_2017 | 13F-HR | 31 | $160,058,000 | 13.22% |
| 2017-02-16 | 2016-12-31 | Q4_2016 | 13F-HR/A | 27 | $141,372,000 | 0.00% |
| 2017-02-14 | 2016-12-31 | Q4_2016 | 13F-HR | 27 | $1,413,712,000 | 349.93% |
| 2016-11-10 | 2016-09-30 | Q3_2016 | 13F-HR/A | 31 | $314,204,000 | 0.00% |
| 2016-11-09 | 2016-09-30 | Q3_2016 | 13F-HR | 31 | $314,204,000 | 20.52% |
| 2016-08-15 | 2016-06-30 | Q2_2016 | 13F-HR | 28 | $260,704,000 | -8.58% |